DocuSign, Inc. (NASDAQ:DOCU) Position Increased by Stifel Financial Corp

Stifel Financial Corp increased its stake in DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 8.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 85,637 shares of the company's stock after purchasing an additional 6,525 shares during the period. Stifel Financial Corp's holdings in DocuSign were worth $7,702,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Rhumbline Advisers boosted its position in DocuSign by 118.8% during the 4th quarter. Rhumbline Advisers now owns 608,123 shares of the company's stock worth $54,695,000 after acquiring an additional 330,136 shares during the period. KBC Group NV grew its position in DocuSign by 32.7% in the 4th quarter. KBC Group NV now owns 1,535,107 shares of the company's stock valued at $138,067,000 after buying an additional 378,233 shares in the last quarter. Jennison Associates LLC bought a new position in DocuSign in the 4th quarter valued at about $12,897,000. Everence Capital Management Inc. bought a new position in DocuSign in the 4th quarter valued at about $720,000. Finally, Principal Financial Group Inc. grew its position in DocuSign by 3,026.7% in the 4th quarter. Principal Financial Group Inc. now owns 546,796 shares of the company's stock valued at $49,179,000 after buying an additional 529,308 shares in the last quarter. Institutional investors own 77.64% of the company's stock.

Analyst Upgrades and Downgrades

DOCU has been the subject of a number of recent analyst reports. Bank of America decreased their target price on shares of DocuSign from $112.00 to $98.00 and set a "neutral" rating for the company in a research report on Friday, March 14th. HSBC upgraded shares of DocuSign from a "reduce" rating to a "hold" rating and set a $70.00 price objective for the company in a research report on Friday, April 11th. Hsbc Global Res upgraded shares of DocuSign from a "moderate sell" rating to a "hold" rating in a research report on Friday, April 11th. UBS Group reduced their price objective on shares of DocuSign from $90.00 to $85.00 and set a "neutral" rating for the company in a research report on Thursday, April 17th. Finally, JPMorgan Chase & Co. upgraded shares of DocuSign from an "underweight" rating to a "neutral" rating and raised their price objective for the company from $70.00 to $75.00 in a research report on Monday, March 10th. One equities research analyst has rated the stock with a sell rating, eleven have assigned a hold rating and four have given a buy rating to the stock. According to data from MarketBeat.com, DocuSign presently has a consensus rating of "Hold" and an average price target of $92.46.

DocuSign Price Performance

NASDAQ DOCU opened at $82.03 on Tuesday. The company has a 50 day simple moving average of $80.25 and a 200-day simple moving average of $83.87. The firm has a market capitalization of $16.61 billion, a price-to-earnings ratio of 16.91, a price-to-earnings-growth ratio of 6.94 and a beta of 1.20. DocuSign, Inc. has a 52-week low of $48.70 and a 52-week high of $107.86.

DocuSign (NASDAQ:DOCU - Get Free Report) last posted its quarterly earnings results on Thursday, March 13th. The company reported $0.86 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.84 by $0.02. The business had revenue of $776.25 million during the quarter, compared to analyst estimates of $760.94 million. DocuSign had a net margin of 34.73% and a return on equity of 14.90%. The firm's revenue was up 9.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.76 earnings per share. On average, analysts predict that DocuSign, Inc. will post 1.17 EPS for the current year.

Insider Transactions at DocuSign

In related news, Director Teresa Briggs sold 534 shares of the firm's stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $87.41, for a total transaction of $46,676.94. Following the transaction, the director now owns 8,270 shares of the company's stock, valued at approximately $722,880.70. This trade represents a 6.07 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Robert Chatwani sold 15,706 shares of the firm's stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $83.19, for a total transaction of $1,306,582.14. Following the transaction, the insider now directly owns 76,842 shares in the company, valued at approximately $6,392,485.98. The trade was a 16.97 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 55,851 shares of company stock valued at $4,607,439 over the last three months. 1.66% of the stock is owned by corporate insiders.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.